Should the management of sepsis in immunocompromised patients differ from that of febrile neutropenia in haematology and oncology patients?

No direct comparative evidence between sepsis and febrile neutropenia management in immunocompromised patients was identified. However, both conditions require urgent treatment, often with broad-spectrum antibiotics, and existing guidelines should be adapted pragmatically to specific patient needs.